Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use

JAMA Internal Medicine

Volumn 176, Issue 8, 2016, Pages 1223-1225

  Schaffer, Andrea L ^a   Buckley, Nicholas A ^b   Cairns, Rose ^c   Pearson, Sallie Anne ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; DIAZEPAM; NEUROLEPTIC AGENT; NITRAZEPAM; OXAZEPAM; PRESCRIPTION DRUG; TEMAZEPAM; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADULT; ADVERSE OUTCOME; AGED; AUSTRALIA; CLINICAL ASSESSMENT; DRUG CONTROL; DRUG DOSE REGIMEN; DRUG INTOXICATION; DRUG MISUSE; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; POPULATION; PRESCRIPTION; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TREATMENT DURATION; CLINICAL PRACTICE; EPIDEMIOLOGY; LEGISLATION AND JURISPRUDENCE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; ALPRAZOLAM; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; AUSTRALIA; BENZODIAZEPINES; DIAZEPAM; DRUG AND NARCOTIC CONTROL; DRUG SUBSTITUTION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTERRUPTED TIME SERIES ANALYSIS; MALE; MIDDLE AGED; OXAZEPAM; PRACTICE PATTERNS, PHYSICIANS';

EID: 84980332016     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.2992     Document Type: Letter

References (7)

1. Isbister GK, O'Regan L, Sibbritt D, Whyte IM. Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol. 2004;58(1): 88-95.
2. Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. J Clin Psychopharmacol. 2011;31(5):647-652.
3. Rintoul AC, Dobbin MD, Nielsen S, Degenhardt L, Drummer OH. Recent increase in detection of alprazolam in Victorian heroin-related deaths. Med J Aust. 2013;198(4):206-209.
4. Department of Health Therapeutic Goods Administration. Scheduling delegate's final decisions: ACCS/ACMS, June 2013. 2013; https://www.tga.gov.au/book/part-scheduling-proposals-referred-march-2013-meeting-acms. Accessed May 19, 2016.
5. Mellish L, Karanges EA, Litchfield MJ, et al. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers. BMC Res Notes. 2015;8:634.
6. Jones CM, Lurie PG, Throckmorton DC. Effect of US Drug Enforcement Administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing. JAMA Intern Med. 2016;176(3):399-402.
7. Fisher J, Sanyal C, Frail D, Sketris I. The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature. J Clin Pharm Ther. 2012;37(1):7-21.